Robert Goldel, Ph.D., came to PIF and FDA from Boston, Massachusetts where he is a founder, neuroscientist, and data-driven technologist developing innovations with impact in digital biomarkers and software as medicine. At Neumitra, his team launched the first smart watch to measure and manage the physiology of the nervous system with real-time biofeedback, personalized mobile software, and cloud-based analytics. His work has been supported by the National Science Foundation, the National Institutes of Health, Breakout Labs at the Thiel Foundation, the Defense Advanced Research Projects Agency, and the founders and innovators of Boston Scientific, General Magic, iRobot, and Yahoo. Robert is passionate about startup ecosystems and where brain health affects basic cognitive functions like learning and attention.
A new PIF team has begun their work applying data science approaches to device, drug, and software development, and associated regulatory decisions.
Read More →